30.04.2014 MediClin AG  DE0006595101

DGAP-News: MediClin achieved a considerable sales increase and result improvements in the first quarter of 2014 against the comparable previous year's quarter


 
DGAP-News: MediClin AG / Key word(s): Quarter Results MediClin achieved a considerable sales increase and result improvements in the first quarter of 2014 against the comparable previous year's quarter 30.04.2014 / 13:31 --------------------------------------------------------------------- MediClin achieved a considerable sales increase and result improvements in the first quarter of 2014 against the comparable previous year's quarter Offenburg, April 30, 2014 - In the first quarter of 2014 MEDICLIN Aktiengesellschaft (MediClin) achieved Group sales in the amount of EUR 132.4 mill. (Q1 2013: EUR 124.5 mill.) thus being EUR 7.9 mill. or 6.4 % above the value of the first quarter 2013. All segments contributed to sales increase. The occupancy rate of the Group improved to 86.1 % (Q1 2013: 83.9 %) against previous year. Material expenses and depreciation and amortisation were nearly on previous year's level, staff costs and other operating expenses increased moderate. In comparision with the previous year the Group operating result improved by EUR 4.9 mill. from EUR -5.9 mill. to EUR -1.0 mill. The financial result was EUR -1.0 mill. (Q1 2013: EUR -0,8 mill.). The result after tax attributable to shareholders of MediClin AG of the first quarter 2014 improved by EUR 4.8 mill. from EUR -6,5 mill. to EUR -1.7 mill. Considerable improvement of the result of the acute segment The quarterly comparison shows that sales of the post-acute segment of EUR 74.0 mill. was EUR 3.3 mill. and sales of the acute segment of EUR 54.4 mill. was EUR 4.8 mill. or 9.8 % up against previous year's values. The nursing care business area showed sales of EUR 3.3 mill. on previous year's level. Higher sales and less increase of expenses than sales led to result improvements in the two above-named segments. The segment result of post-acute was EUR -1.8 mill. (Q1 2013: EUR -4.2 mill.), the result of the acute segment EUR 3.1 mill. (Q1 2013: EUR 0.1 mill.). In the first quarter of 2014 EUR 5.0 mill. (Q1 2013: EUR 4.8 mill.) were invested in fixed assets (brutto). As of March 31, 2014 cash and cash equivalents were EUR 11.1 mill. (31.12.2013: EUR 10.0 mill.) and the equity ratio was 47,5 % (31.12.2013: 48.1 %). MediClin employed on average 6,364 employees (Q1 2013: 6,352 employees), calculated on the basis of full-time staff, in the first quarter of 2014. Outlook Based on the good start in the new financial year and based on sales and result improvements coming from initiated measurements the Management Board members assume that the target margins of the Group and the segments are achievable. The interim report as of March 31, 2014 will be available in German and English from May 9, 2014 under www.mediclin.de. About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 11 Medizinische Versorgungszentren (medical care units) in 11 federal states MediClin has a total capacity of approximately 8,100 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,500 employees. MediClin ─ a company of the Asklepios Group. End of Corporate News --------------------------------------------------------------------- 30.04.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MediClin AG Okenstraße 27 77652 Offenburg Germany Phone: +49 (0)781 488-189 Fax: +49 (0)781 488-184 E-mail: [email protected] Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 265801 30.04.2014


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 609,08 645,11 673,09 659,86 673,14 704,70 730,07
EBITDA1,2 27,01 37,35 93,58 77,50 85,22 90,92 98,73
EBITDA-Marge3 4,43 5,79 13,90 11,74 12,66 12,90
EBIT1,4 6,62 15,06 22,41 0,15 11,56 19,52 12,72
EBIT-Marge5 1,09 2,33 3,33 0,02 1,72 2,77 1,74
Jahresüberschuss1 3,96 7,76 9,68 -0,04 1,49 9,72 -10,72
Netto-Marge6 0,65 1,20 1,44 -0,01 0,22 1,38 -1,47
Cashflow1,7 19,34 29,77 69,59 118,69 81,97 34,64 78,00
Ergebnis je Aktie8 0,08 0,16 0,20 -0,19 0,03 0,20 -0,23
Dividende8 0,05 0,05 0,05 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Mediclin
WKN Kurs in € Einschätzung Börsenwert in Mio. €
659510 2,860 Halten 135,85
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
11,00 19,31 0,55 21,50
KBV KCV KUV EV/EBITDA
0,69 1,74 0,19 1,58
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 06.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
02.05.2024 31.07.2024 04.11.2024 26.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
10,77% 5,11% 4,38% -3,38%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MediClin AG  ISIN: DE0006595101 können Sie bei EQS abrufen


Pflegeeinrichtungen , 659510 , MED , XETR:MED